Skip to main content
EOFlow Co., Ltd. logo

EOFlow Co., Ltd. — Investor Relations & Filings

Ticker · 294090 ISIN · KR7294090006 KO Manufacturing
Filings indexed 461 across all filing types
Latest filing 2022-09-21 AGM Information
Country KR South Korea
Listing KO 294090

About EOFlow Co., Ltd.

https://www.eoflow.com

EOFlow Co., Ltd. is a medical device company that develops and provides wearable drug delivery solutions. Its flagship product is the EOPatch, a disposable, wearable insulin pump system designed for the continuous delivery of insulin to manage blood glucose levels in individuals with diabetes. The company leverages its proprietary technology and manufacturing expertise to create reliable and accessible drug delivery platforms. EOFlow also collaborates with partners to integrate its pump technology into automated insulin delivery (AID) systems, advancing diabetes care management.

Recent filings

Filing Released Lang Actions
주주총회소집결의(임시주주총회)
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for the company EOFLOW. It details the agenda items, including the appointment of directors and auditors, and provides specific biographical and career information for the candidates. This type of document is a standard proxy solicitation or information statement provided to shareholders to inform them of upcoming meeting agenda items and to request their participation/votes.
2022-09-21 Korean
기타경영사항(자율공시)(이오패치 아랍에미리트 품목허가 취득)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'voluntary disclosure' (기타 경영사항(자율공시)) concerning the acquisition of a product license (EOPatch) in the United Arab Emirates. Since it does not fit into specific categories like financial reports, dividends, or director dealings, and is a standard regulatory announcement of a material business event, it falls under the general regulatory filing category.
2022-08-31 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company '이오플로우 주식회사' covering the period from 2022-01-01 to 2022-06-30. It contains detailed financial information, business operations, management discussions, and corporate governance details. According to the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year (like a half-year report) is classified as an Interim / Quarterly Report (IR). H1 2022
2022-08-16 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (EOFlow) announcing a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, counterparty, and duration. Since this is a specific regulatory disclosure regarding a business contract that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-07-25 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) between Eoflow and Sinoflow Co., Ltd. This type of disclosure, which details specific contract terms, amounts, and counterparties, does not fit into categories like financial reports, presentations, or governance. In the context of Korean regulatory filings (DART), this is a standard material event disclosure. Since it does not fit the specific categories provided, it falls under the 'Regulatory Filings' (RNS) fallback category.
2022-07-13 Korean
[기재정정]타법인주식및출자증권취득결정(종속회사의주요경영사항)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from a Korean company (EOFlow) regarding an amendment to a previous disclosure about the acquisition of shares in another company (SanPlena, LLC). It details the delay in capital payment and updates the expected acquisition date. This falls under the category of general regulatory announcements or corporate filings that do not fit into specific categories like M&A (as it is an internal subsidiary investment/capital contribution) or share issuance, making 'RNS' (Regulatory Filings) the most appropriate classification.
2022-06-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.